Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
21 current organization shown on this profile
Board positions
11 supported by public sources, 0 supplied by the profile owner
Committee roles
Not establishedNo committee role is currently confirmed by the cited sources
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

Professor Stevens has served as Chief Executive Officer of Structure Therapeutics since May 2019 and previously as Provost Professor at USC. He is considered among the world's most influential biomedical scientists in molecular research and has been involved in the creation of therapeutic molecules that led to breakthrough drugs.

Sources are shown with the information they support.

Current roles

Appointments & responsibilities

Board appointments

Governance

Board appointments, committee responsibilities and disclosed relationships.

Board and advisory record

Board service

Sources are shown with each role, education record, or credential.

Independent Director

Danaher Corporation

2017-01-01 · current

Confirmed by public sourceView source

Director

Danaher Corporation

Current · start date not disclosed

Confirmed by public sourceView source

Connections

Explore the roles, education and affiliations published in this record.

Danaher Corporation

Open Danaher Corporation profile →

Independent Director at Danaher Corporation

2017-01-01 → End not stated

current · source reported

Observed: 2026-09-21

Director at Danaher Corporation

Start not stated → End not stated

current · source reported

Observed: 2026-09-21

Danaher CorporationDanaher CorporationRaymond C. Stevens

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec FilingDanaher director board sourceSupports Board membership, Committee assignments, Director since, Board independence.Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:raymond-c-stevens
Record version
public-0

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

Board independence · Source reportedIndependent director1 source
Verification
Source reported
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Board membership · CorroboratedServes on the board of DanaherSupported by 4 public records2 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Committee assignments · Source reportedNo committee assignment disclosed in the cited filing1 source
Verification
Source reported
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

View all sources4 records
  1. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: Board membership · Committee assignments · Director since · Board independence

  2. https://www.sec.gov/Archives/edgar/data/313616/000031361626000101/dhr-20260325.htm

    Sec Proxy · Tier not stated · Reviewed Mar 25, 2026

    Supports: Independent Director at Danaher Corporation (NYSE: DHR)

  3. https://www.sec.gov/Archives/edgar/data/313616/000031361626000101/dhr-20260325.htm

    Sec Def 14a · Tier not stated · Reviewed Sep 14, 2026

    Supports: Director at Danaher Corporation (NYSE: DHR)

  4. https://www.sec.gov/Archives/edgar/data/313616/000031361626000101/dhr-20260325.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership